Michelin, a Fortune 500 consumer good manufacturing company and the global leader in tyre manufacturing, works with Magnitude Biosciences for a sustainable, ethical solution for whole organism toxicity testing.
Take a look at our Poster from ELRIG Drug Discovery 2021: Automated Monitoring of C. elegans Movement for Neurodegeneration and Ageing.
Determine whether caloric restriction could be involved in your test compound's mode of action.
Just published in Frontiers in Aging: Applying C. elegans to industrial drug discovery
The joint project for Magnitude Biosciences, Perfectus Biomed Group and the University of Kent aims to provide an assay to aid research on infections caused by Pseudomonas aeruginosa, delivering a solution to accelerate wound care research and reduce the reliance on mammalian testing. The project focuses on developing an industrial whole organism assay for biofilms […]
Hannah Raddings (right) and Alana Mullins (centre) with Magnitude Biosciences Head of Experiments Michael Fasseas (left) Durham, UK - July 29, 2021 Magnitude Biosciences, the world’s leading commercial lab services provider in using the nematode worm C. elegans to accelerate drug discovery and other research in the areas of the gut microbiome, ageing, and neurodegeneration, […]
